Applied Materials CapEx decreased by 1.7% to $635.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 24.5%, from $510.00M to $635.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 35.6% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $204.00M | $137.00M | $206.00M | $144.00M | $210.00M | $210.00M | $223.00M | $287.00M | $255.00M | $255.00M | $309.00M | $229.00M | $257.00M | $297.00M | $407.00M | $381.00M | $510.00M | $584.00M | $785.00M | $646.00M | $635.00M |
| QoQ Change | — | -32.8% | +50.4% | -30.1% | +45.8% | +0.0% | +6.2% | +28.7% | -11.1% | +0.0% | +21.2% | -25.9% | +12.2% | +15.6% | +37.0% | -6.4% | +33.9% | +14.5% | +34.4% | -17.7% | -1.7% |
| YoY Change | — | — | — | — | +2.9% | +53.3% | +8.3% | +99.3% | +21.4% | +21.4% | +38.6% | -20.2% | +0.8% | +16.5% | +31.7% | +66.4% | +98.4% | +96.6% | +92.9% | +69.6% | +24.5% |